OnKure Therapeutics, Inc. (OKUR) Misses Q4 EPS by 130c
Tweet
Share
E-mailGet Alerts OKUR Hot Sheet
Join SI Premium – FREE
OnKure Therapeutics, Inc. (NASDAQ: OKUR) reported Q4 EPS of ($1.37), $1.30 worse than the analyst estimate of ($0.07).
For earnings history and earnings-related data on OnKure Therapeutics, Inc. (OKUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Bath & Body Works to Buy with $25 price target
- Pony AI (PONY) Reports Revenue Above Estimates
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
